
Factors Linked to Very Preterm Delivery Despite Transabdominal Cerclage
Transabdominal cerclage (TAC) remains a cornerstone for preventing recurrent pregnancy loss in high-risk women. Nevertheless, clinicians must acknowledge that transabdominal cerclage preterm delivery can still occur in specific cohorts. A recent observational study at a London hospital evaluated 125 pregnancies to identify why some procedures fail. Researchers discovered that while the overall success rate is high, approximately 6.4% of women delivered before the 32-week mark. Consequently, understanding these clinical characteristics is essential for improving maternal and neonatal outcomes.
Risk Factors for Transabdominal Cerclage Preterm Delivery
The most significant predictor of delivery before 32 weeks is a history of trachelectomy. Specifically, patients with this surgical history faced a substantially higher risk compared to those with other indications for cerclage. In contrast, factors such as maternal age, body mass index, or smoking status did not show a strong correlation with failure. Furthermore, the study found no significant difference between laparoscopic and open surgical techniques. Therefore, the anatomical changes from previous cervical surgery appear more critical than the operative method itself.
Additionally, the timing of the stitch insertion—whether performed before or during pregnancy—did not impact the likelihood of preterm birth. However, clinicians should remain vigilant about cervical length monitoring. Although postoperative cervical length was not a statistically significant predictor in this study, maintaining a long cervix remains a general goal in high-risk obstetrics. Ultimately, these findings allow doctors to provide more accurate counseling to women considering TAC, particularly those with a history of radical cervical procedures.
Frequently Asked Questions
How successful is transabdominal cerclage in preventing very preterm birth?
Transabdominal cerclage is highly effective, with studies showing success rates over 93%. Only a small fraction of patients (around 6.4%) deliver before 32 weeks of gestation according to recent clinical data.
Does a previous trachelectomy affect the outcome of a transabdominal cerclage?
Yes, a history of trachelectomy is a major risk factor for preterm delivery even with a transabdominal stitch. Patients with this history require intensive monitoring and realistic counseling regarding their obstetric risks.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or establish a doctor-patient relationship. Always seek the advice of a qualified healthcare provider regarding any medical condition or treatment. Refer to the latest local and national guidelines for clinical practice.
References
van der Krogt L et al. Clinical Characteristics Associated With Very Preterm Delivery Despite Transabdominal Cerclage: A Cohort Study. BJOG. 2026 Feb 16. doi: 10.1111/1471-0528.70177. PMID: 41699431.
Clark NV, Einarsson JI. Laparoscopic abdominal cerclage: a highly effective option for refractory cervical insufficiency. Fertility and Sterility. 2020 Apr 1;113(4):717-22.
Son G, Ham H, et al. Outcomes after transabdominal cerclage in twin pregnancy with previous unsuccessful transvaginal cerclage. PLoS ONE. 2020;15(4):e0232264.

More from MedShots Daily

A cohort study identifies that while transabdominal cerclage is highly effective, previous trachelectomy significantly increases the risk of delivery before...
last month

Researchers developed a statistical framework using ΔCq values to optimize GMO soybean quantification, reducing costs and resource waste in testing laborato...
Today

A study of 13,627 children finds that higher maternal fasting glucose is linked to a higher risk of failing early educational milestones at age five....
Today

A systematic review analyzing how recipient twin cardiomyopathy affects survival and the potential benefits of perioperative calcium channel blockers....
Today

New research identifies MEX3B as a post-transcriptional activator of TLR4, promoting inflammation and cartilage breakdown in osteoarthritis progression....
Today

A comparative study shows VAMS offers better precision and 24-hour stability than DBS for profiling signaling lipids, supporting its use in clinical lipidom...
Today